Studies in endocrinology, diabetology
with ongoing recruitmentD6973C00001 BaxDuo Prevent-HF
| Target group: | Patients with type 2 diabetes mellitus and known concomitant cardiovascular disease (myocardial infarction, stroke, circulatory disorders) |
| Aim of the study: | Investigation of the efficacy of baxdrostat/dapagliflozin compared to placebo/dapagliflozin in preventing the development of heart failure (cardiac insufficiency) |
| Contact person: | Prof. Dr. med. Jochen Seufert |
IMVT-1402-2502
| Target group: | Adult patients with Graves' disease |
| Study objective: | To evaluate the efficacy, safety and tolerability of IMVT-1402 (antibody) compared to placebo. |
| Contact person: | Prof. Dr. Jochen Seufert |
Study Assistance Contact | +49 (0) 761 270-32618 |
Project Coordination Contact | +49 (0) 761 270-32613 +49 (0) 761 270-32622 |